Tekturna (aliskiren) / PDL, Novartis  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
2009-016077-14: Role of ALiskiren, a direct renin inhibitor, in preventing atrial Fibrillation in patients with a pacemaker; RALFEteisvärinäkuorman määritys sydämentahdistimella aliskireenihoidossa

Ongoing
4
70
Europe
Rasilez, Rasilez
Mika Lehto
Patients who have a pacemaker due to sinus node disease and paroxysmal atrial fibrillation.
 
 
2011-002587-24: Effect of Aliskiren drug in patients with high blood pressure Effetto del farmaco Aliskiren in pazienti con pressione alta

Ongoing
4
42
Europe
ENALAPRIL S.G.*28CPR 5MG, RASILEZ*56CPR RIV 150MG, ENALAPRIL S.G.*28CPR 5MG, RASILEZ*56CPR RIV 150MG
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR, Novartis
dysfunction of coronary microcirculation in arterial hypertension disfunzione del microcircolo coronarico nell\'ipertensione arteriosa
 
 
ChiCTR1900028215: Treatment of Obstructive Sleep Apnea Syndrome Related Hypertension with Aliskiren (Rasilez): a Single Center, One-Armed, Open-Label Clinical Trial.

Recruiting
4
30
 
Aliskiren
Beijing Anzhen Hospital, Capital Medical University; Beijing Anzhen Hospital, Zhaoke Pharmaceutical (Hefei) Co. Ltd.
Hypertension in Obstructive Sleep Apnea Syndrome(OSAS) patients
 
 

Download Options